{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:23:54Z","timestamp":1774538634203,"version":"3.50.1"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T00:00:00Z","timestamp":1425600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0119260","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T14:00:43Z","timestamp":1425650443000},"page":"e0119260","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":27,"title":["QuantiFERON-TB Gold In-Tube Assay for Screening Arthritis Patients for Latent Tuberculosis Infection before Starting Anti-Tumor Necrosis Factor Treatment"],"prefix":"10.1371","volume":"10","author":[{"given":"Hyun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Yun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyeongman","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong-Ho","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Won","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaejoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoon-Suk","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Mi","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Suk","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Jung","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,3,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e30275","DOI":"10.1371\/journal.pone.0030275","article-title":"Systematic review and meta-analysis of the efficacy and safety of existing TNF blocking agents in treatment of rheumatoid arthritis","volume":"7","author":"KJ Aaltonen","year":"2012","journal-title":"PLoS One"},{"key":"ref2","unstructured":"Callhoff J, Sieper J, Weiss A, Zink A, Listing J. Efficacy of TNF-\u03b1 blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis. Ann Rheum Dis [Epub ahead of print] doi:101136\/annrheumdis-2014-205322. 2014."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1-neutralizing agent","volume":"345","author":"J Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","article-title":"Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report","volume":"48","author":"JJ Gomez-Reino","year":"2003","journal-title":"Arthritis Rheum"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","article-title":"The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement","volume":"36","author":"I Solovic","year":"2010","journal-title":"Eur Respir J"},{"issue":"Suppl 2","key":"ref6","doi-asserted-by":"crossref","first-page":"ii2","DOI":"10.1136\/annrheumdis-2013-203348","article-title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012","volume":"72","author":"DE Furst","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.62.8.791","article-title":"French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers","volume":"62","author":"X Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","article-title":"BTS recommendations for assessing risk and for managing <italic>Mycobacterium tuberculosis<\/italic> infection and disease in patients due to start anti-TNF-\u03b1 treatment. British Thoracic Society Standards of Care Committee","volume":"60","year":"2005","journal-title":"Thorax"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"L Carmona","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref10","first-page":"247","article-title":"Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience","volume":"31","author":"JE Fonseca","year":"2006","journal-title":"Acta Reumatol Port"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1136\/annrheumdis-2011-200408","article-title":"Influence of replacing tuberculin skin test with ex vivo interferon \u03b3 release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy","volume":"71","author":"X Mariette","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.semarthrit.2012.07.001","article-title":"Factors influencing discrepancies between the QuantiFERON-TB gold in tube test and the tuberculin skin test in Korean patients with rheumatic diseases","volume":"42","author":"JH Kim","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2004.029041","article-title":"Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis","volume":"64","author":"D Ponce de Leon","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of <italic>Mycobacterium tuberculosis<\/italic> infection","volume":"27","author":"M Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"M Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/ard.2007.069799","article-title":"Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy","volume":"66","author":"J Sellam","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"ref17","first-page":"776","article-title":"Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population","volume":"35","author":"D Ponce de Leon","year":"2008","journal-title":"J Rheumatol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","article-title":"Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a <italic>Mycobacterium tuberculosis<\/italic> antigen-specific interferon gamma assay","volume":"67","author":"G Matulis","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"ref19","first-page":"620","article-title":"Screening for tuberculosis infection before the initiation of an anti-TNF-\u03b1 therapy","volume":"137","author":"C Beglinger","year":"2007","journal-title":"Swiss Med Wkly"},{"key":"ref20","first-page":"329","article-title":"Recommendations for tuberculosis screening before initiation of TNF-\u03b1-inhibitor treatment in rheumatic diseases","volume":"63","author":"R Diel","year":"2009","journal-title":"Pneumologie"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/BOR.0b013e3283474d62","article-title":"Interferon-\u03b3 release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders","volume":"23","author":"R Smith","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1136\/annrheumdis-2011-200941","article-title":"Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-\u03b3 release assays under real-life conditions","volume":"71","author":"S Kleinert","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/thoraxjnl-2013-203436","article-title":"Evaluation of screening methods for identification of patients with chronic rheumatological disease requiring tuberculosis chemoprophylaxis prior to commencement of TNF-\u03b1 antagonist therapy","volume":"68","author":"A Singanayagam","year":"2013","journal-title":"Thorax"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"428","DOI":"10.5588\/ijtld.13.0644","article-title":"The &apos;either test positive&apos; strategy for latent tuberculous infection before anti-tumour necrosis factor treatment","volume":"18","author":"YJ Jung","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s10067-011-1771-9","article-title":"Interferon-\u03b3 release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea","volume":"30","author":"B Chang","year":"2011","journal-title":"Clin Rheumatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4046\/trd.2013.74.3.104","article-title":"Increased tuberculosis burden due to demographic transition in Korea from 2001 to 2010","volume":"74","author":"YK Park","year":"2013","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"FC Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"S van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"ref29","unstructured":"Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. Available at <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/tbfree.cdc.go.kr\/tbfree\/guide.do?page=11&id=4110\" xlink:type=\"simple\">http:\/\/tbfree.cdc.go.kr\/tbfree\/guide.do?page=11&amp;id=4110<\/ext-link> [accessed on 22 December 2014] [in Korean]. 2011."},{"key":"ref30","unstructured":"Korea Centers for Disease Control and Prevention. Korean guidelines for tuberculosis. Available at <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.lungkorea.org\/thesis\/file\/korean_guidelines_for_tuberculosis_2014.pdf\" xlink:type=\"simple\">http:\/\/www.lungkorea.org\/thesis\/file\/korean_guidelines_for_tuberculosis_2014.pdf<\/ext-link> [accessed on 22 December 2014] [in Korean]. 2014."},{"key":"ref31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/acr.21641","article-title":"2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis","volume":"64","author":"JA Singh","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref32","first-page":"1192","article-title":"False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria?","volume":"10","author":"M Farhat","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00296-009-1027-z","article-title":"Prevalence of positive ppd in a cohort of rheumatoid arthritis patients","volume":"30","author":"MN Tamborenea","year":"2010","journal-title":"Rheumatol Int"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1086\/338149","article-title":"Evolution and current use of the tuberculin test","volume":"34","author":"E Lee","year":"2002","journal-title":"Clin Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/art.34382","article-title":"Interferon-\u03b3 release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis","volume":"64","author":"EC Hsia","year":"2012","journal-title":"Arthritis Rheum"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/annrheumdis-2012-201979","article-title":"You can&apos;t always get what you want, but if you try sometimes (with two tests-TST and IGRA-for tuberculosis) you get what you need","volume":"71","author":"KL Winthrop","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrrheum.2013.82","article-title":"Bedfellows: mycobacteria and rheumatoid arthritis in the era of biologic therapy","volume":"9","author":"KL Winthrop","year":"2013","journal-title":"Nat Rev Rheumatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4046\/trd.2014.76.6.261","article-title":"Diagnosis and treatment of latent tuberculosis infection due to initiation of anti-TNF therapy","volume":"76","author":"TS Shim","year":"2014","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1016\/j.rmed.2013.08.011","article-title":"Incidence of tuberculosis among anti-tumor necrosis factor users in patients with a previous history of tuberculosis","volume":"107","author":"KW Jo","year":"2013","journal-title":"Respir Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","article-title":"Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden","volume":"52","author":"J Askling","year":"2005","journal-title":"Arthritis Rheum"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jbspin.2010.12.004","article-title":"Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review","volume":"78","author":"L Baronnet","year":"2011","journal-title":"Joint Bone Spine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/keq242","article-title":"Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly","volume":"50","author":"JB Galloway","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/annrheumdis-2011-200489","article-title":"Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNF\u03b1 inhibitors: the utility of IFN\u03b3 assay","volume":"71","author":"DY Chen","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3346\/jkms.2014.29.8.1090","article-title":"Follow-up testing of interferon-gamma release assays are useful in ankylosing spondylitis patients receiving anti-tumor necrosis factor alpha for latent tuberculosis infection","volume":"29","author":"CN Son","year":"2014","journal-title":"J Korean Med Sci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1086\/506935","article-title":"Antirheumatic drugs and the risk of tuberculosis","volume":"43","author":"P Brassard","year":"2006","journal-title":"Clin Infect Dis"},{"key":"ref46","first-page":"706","article-title":"Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers","volume":"34","author":"SS Seong","year":"2007","journal-title":"J Rheumatol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/art.23285","article-title":"Mathematical modeling of the cause of tuberculosis during tumor necrosis factor blockade","volume":"58","author":"RS Wallis","year":"2008","journal-title":"Arthritis Rheum"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","article-title":"Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry","volume":"60","author":"F Tubach","year":"2009","journal-title":"Arthritis Rheum"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)","volume":"69","author":"WG Dixon","year":"2010","journal-title":"Ann Rheum Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0119260","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T10:30:31Z","timestamp":1540204231000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0119260"}},"subtitle":[],"editor":[{"given":"Jean Louis","family":"Herrmann","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,6]]},"references-count":49,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0119260","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,6]]}}}